Lunch & Learn: PCR, ANtigen & Antibody tests. What is the difference?

We look forward to you joining us on Thursday, March 25, 2021 at 12:00 EST for a Lunch & Learn webinar titled: PCR, Antigen and Antibody Tests. What is the Difference?

Presented by Dr. Amanda Naaum, the Scientific Liaison

Director at Precision Biomonitoring. Dr. Eric Hoskins, former Ontario Minister of Health will co-host the event and answer any questions during the the Q&A session.

Hosted by
Precision Biomonitoring
Eric Hoskins and
Amanda Naaum
March 25th | 12:00 EDT | Show in my timezone

Broadcast has ended. You may watch the replay!

You can still register and watch the replay!


Here is What You'll Learn

Review testing methods

Review all the various testing methods and highlight the major differences between antigen, antibody and qPCR testing.

Testing Applications

Examine when and how each of these tests is useful and helpful in detecting the virus.

Testing limitations

Review the limitations of each tests and how that applies in testing scenarios.

Testing Implementation

Review how these tests can be implemented in various scenarios to help re-open the economy.


Speaker Amanda Naaum

Dr. Amanda Naaum has over ten years of experience in molecular assay development for species identification in both academic and start-up industry settings. Amanda holds a Ph.D. from the University of Guelph. Dr. Naaum was awarded the IUFoST Young Scientist Award (2016), and a Commonwealth Rutherford Fellowship (2018) in recognition of her research and innovation achievements in point of need food species authenticity testing. She now extends this expertise to applications for food and animal safety and environmental monitoring at PBI.


Co-host Eric Hoskins

Eric is a medical doctor with a PhD in Public Health and Epidemiology from Oxford. An Order of Canada recipient, Eric has worked in health systems in Canada and around the world. He was Ontario’s Minister of Health from 2014-2018, and Minister of Economic Development and Trade from 2013-2014. Most recently, Eric was Chair of the Federal Advisory Council on the Implementation of National Pharmacare, and has been

advising the private sector on COVID-19 since the pandemic began. Eric brings his knowledge of health care and innovation to his role as Board director. 

March 25th
12:00 EDT